EX-10.20.C



 







EXHIBIT 10.20(c)




AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENT




          THIS AMENDMENT NO. 2 TO TRANSITION AND SUCCESSION AGREEMENT (this “Amendment”) by and between
Mylan Laboratories Inc., a Pennsylvania corporation (the “Company”), and Edward J. Borkowski (the
“Executive”), is made as of April 3, 2006.




          WHEREAS, the Company and the Executive are parties to that certain Transition and Succession
Agreement dated as of December 15, 2003, as amended December 2, 2004 (as amended, the “Agreement”);




          WHEREAS, the Company and the Executive wish to amend the Agreement, effective as of April 1,
2006, as set forth below;




          NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which are
hereby acknowledged, the parties hereto, intending to be legally bound, agree as follows:





	 	1.	 	Section 1(a) of the Agreement is hereby amended to add the following sentence at the
end of such subsection:






“For the sake of clarity, it is understood that if the Executive’s employment terminates prior
to the Effective Date other than as described in the preceding sentence, this Agreement shall
thereupon be null and void and of no further force and effect.”




	 	2.	 	The reference to “65%” in Section 1(d)(3) of the Agreement is hereby deleted and
replaced with “60%.”
	 
	 	3.	 	References to the “120-day period” in each of the following sections of the Agreement
shall hereinafter refer to the “180-day period”: 3(a)(1), 3(b)(3), 3(b)(4), 3(b)(5),
3(b)(6), 3(b)(7), 3(b)(8), and 6.
	 
	 	4.	 	The third sentence of 3(b)(1) is hereby deleted and replaced in its entirety with the
following:






“During the Employment Period, the Annual Base Salary shall be reviewed at least annually,
beginning no more than 12 months after the Executive’s last salary review.”




	 	5.	 	Section 3(b)(2) of the Agreement is hereby deleted and replaced in its entirety with
the following:






“Annual Bonus. In addition to the Annual Base Salary, the Executive shall participate in a
bonus program during the Employment Period and have a bonus which is no less favorable than the
bonus for other employees of his level at the Company and its Affiliated Companies.”



 









 






	 	6.	 	The following clause shall be added to the end of section 4(b)(2) of this Agreement:






“which, in the case of clauses (1) and (2), has not been cured within 30 days after a written
demand for substantial performance is delivered to the Executive by the Company that
specifically identifies the manner in which the Company believes that the Executive has grossly
neglected his duties or has engaged in gross misconduct.”




	 	7.	 	Section 4(c)(10) of this Agreement is hereby deleted in its entirety.
	 
	 	8.	 	The penultimate sentence of Section 4(c) of the Agreement is hereby deleted and
replaced in its entirety with the following:






“Anything in this Agreement to the contrary notwithstanding, a termination by the Executive for
any reason pursuant to a Notice of Termination given during the 90-day period immediately
following the first anniversary of the occurrence of a Change in Control (other than a Change
in Control occurring solely under Section 1(d)(3) of this Agreement where all or substantially
all of the individuals and entities that were the beneficial owners of the Outstanding Company
Common Stock and the Outstanding Company Voting Securities immediately prior to a Business
Combination beneficially own, directly or indirectly, more than 50%
of the then-outstanding shares of common stock following the Business Combination) shall be deemed to be a termination
for Good Reason for all purposes of this Agreement.”




	 	9.	 	The introductory clause of Section 5(a)(1) of the Agreement is hereby deleted and
replaced in its entirety to read as follows:






“the Company shall pay to the Executive (or the Executive’s estate or beneficiary, in the event
of the Executive’s death), in a lump sum in cash within 30 days after the Date of Termination
(or, if required by Section 409A of the Code to avoid the imposition of additional taxes, on
the date that is six (6) months following the Date of Termination), the aggregate of the
following amounts:”




	 	10.	 	Section 5(a)(1)(B) of the Agreement is hereby deleted and replaced in its entirety to
read as follows:






“the amount equal to three (3) times the sum of: (i) the Executive’s then-current Annual Base
Salary, plus (ii) an amount equal to the highest bonus determined to date under Section 4(b) of
the Employment Agreement or paid to the Executive hereunder (in the case of death or the
Executive’s Disability, reduced (but not below zero) by any disability or death benefits that
the Executive or the Executive’s estate or beneficiaries are entitled to pursuant to plans or
arrangements of the Company).”




	 	11.	 	Section 5(a)(2) of the Agreement is hereby deleted and replaced in its entirety to
read as follows:




2









 












“For three years after the Executive’s Date of Termination (or such shorter period as required
by Section 409A of the Code to avoid the imposition of additional taxes), the Company shall
continue to provide benefits to the Executive and/or the Executive’s dependents at least equal
to those that were provided to them (taking into account any required employee contributions,
co-payments and similar costs imposed on the Executive and the Executive’s dependents and the
tax treatment of participation in the plans, programs, practices and policies by the Executive
and the Executive’s dependents) by or on behalf of the Company and or the Affiliated Companies
in accordance with the benefit plans, programs, practices and policies (including those
provided under the Employment Agreement) in effect immediately prior to a Change of Control or,
if more favorable to the Executive, as in effect any time thereafter with respect to other peer
executives of the Company and the Affiliated Companies and their dependents; provided, however,
that, if the Executive becomes reemployed with another employer and is eligible to receive such
benefits under another employer provided plan, program, practice or policy, the medical and
other welfare benefits described herein shall be secondary to those provided under such other
plan, program, practice or policy during such applicable period of eligibility; and”




	 	12.	 	Section 9(d) of the Agreement is hereby deleted in its entirety and replaced with the
following:






“The Executive agrees not to voluntarily terminate employment with the Company (other than (i)
as a result of an event that would constitute Good Reason that is at the request of a third
party that has taken steps reasonably calculated to effectuate a Change of Control or otherwise
arose in connection with or in anticipation of a Change of Control or (ii) by reason of
non-extension or non-renewal of the Employment Agreement or such other employment agreement
entered into by and between the Executive and the Company from time to time) from such time as
the Company has entered into an agreement that would result in a Change of Control until the
Change of Control; provided, that such provision shall cease to apply upon the termination of
such agreement or if the Change of Control has not occurred within one year following the
execution of such agreement.”




	 	13.	 	Section 11 of the Agreement is hereby deleted in its entirety and replaced with the
following:






[Intentionally Omitted.]




	 	14.	 	The following section references in Amendment No. 1 to the Transition and Succession
Agreement shall be corrected as follows:






The reference to the last sentence of Section 3(a) of the Agreement shall be to the entirety of
Section 5(a)(2) of the Agreement.



3









 






The reference to Section 3(b) of the Agreement shall be to Section 8 of the Agreement.




	 	15.	 	This Amendment shall be governed by, interpreted under and construed in accordance
with the laws of the Commonwealth of Pennsylvania.
	 
	 	16.	 	This Amendment may be executed in counterparts, each of which shall be an original
and all of which shall constitute the same document.
	 
	 	17.	 	Except as modified by this Amendment, the Agreement is hereby confirmed in all
respects.





          IN WITNESS WHEREOF, this Amendment has been duly executed and delivered as of the date and the
year first written above.




	 	 	 	 	 	 	 
	 	 	MYLAN LABORATORIES INC.
	 
	 	 	 	 	 	 
	 

	 	By: 
	/s/ Robert J. Coury	 	 
	 

	 	 	 	 	 
	 	 	Name: Robert J. Coury
	 	 	Title: Vice Chairman and CEO
	 
	 	 	 	 	 	 
	 	 	EXECUTIVE
	 
	 	 	 	 	 	 
	 	 	  /s/ Edward J. Borkowski
	 	 	 	 	 
	 	 	Edward J. Borkowski







4